Skip to main content
. 2020 Feb 28;72(6):968–975. doi: 10.1093/cid/ciaa188

Table 2.

Underlying Conditions Among Cases and Controls

Condition Case Patients Control Patients P Value
(n = 152) (n = 486)
AIDS 60/152 (39.5) 140/486 (28.8) .0110
Hematologic malignancy 5/152 (3.3) 13/486 (2.7) .9132
Corticosteroids 5/152 (3.3) 17/486 (3.5) .8914
Autoimmune 10/152 (6.6) 44/486 (9.0) .4457
Cancer 4/152 (2.6) 17/486 (3.5) .7773
Lung disease 6/152 (3.9) 69/486 (14.2) .0010
Diabetes 28/152 (18.4) 73/486 (15.0) .3812
Hypertension 22/152 (14.5) 93/486 (19.1) .2430
Liver disease 17/152 (11.2) 51/486 (10.5) .9254
Tuberculosis 5/152 (3.3) 30/486 (6.2) .2443
Miscellaneous 9/152 (5.9) 38/486 (7.8) .5447
None 69/152 (45.4) 162/486 (33.3) .0090

Data are expressed as present/total, no. (%). More than 1 condition was present in some patients.